Aldeyra Reports Full Year 2016 Financial Results

By Sam | March 30, 2017

LEXINGTON, MA–(Marketwired – March 30, 2017) – Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic…
Source: BioSpace

Posted in BioPharma